MY102089A - Antibacterial compounds. - Google Patents

Antibacterial compounds.

Info

Publication number
MY102089A
MY102089A MYPI87002280A MYPI19872280A MY102089A MY 102089 A MY102089 A MY 102089A MY PI87002280 A MYPI87002280 A MY PI87002280A MY PI19872280 A MYPI19872280 A MY PI19872280A MY 102089 A MY102089 A MY 102089A
Authority
MY
Malaysia
Prior art keywords
group
stands
hydrogen atom
compound
antibacterial compounds
Prior art date
Application number
MYPI87002280A
Inventor
Kondo Masahiro
Miyake Akio
Fujino Masahiko
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1984/000270 external-priority patent/WO1985005620A1/en
Priority claimed from PCT/JP1985/000102 external-priority patent/WO1986005184A1/en
Priority claimed from EP85104687A external-priority patent/EP0160252B1/en
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of MY102089A publication Critical patent/MY102089A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A COMPOUND OF THE FORMULA WHEREIN R0 STANDS FOR HYDROGEN ATOM, NITROGEN-CONTAINING HETEROCYCLIC GROUP ACYL GROUP OR ESTERIFIED CARBOXYL GROUP, Z STANDS FOR S, S-O, 013 OR CH2, R4 STANDS FOR HYDROGEN ATOM, METHOXY GROUP OR FORMAMIDO GROUP, R13 STANDS FOR HYDROGEN ATOM, METHYL GROUP, HYDROXYL GROUP OR HALOGEN ATOM AND A STANDS FOR AN OPTIONALLY SUBSTITUTED IMIDAZOL-I-YL GROUP FORMING A CONDENSED RING AT THE 2,3- OR 3,4-POSITION OR A PHYSIOLOGICALLY OR PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF. THIS COMPOUND IS NOVEL AND HAS EXCELLENT ANTIBACTERIAL ACTIVITY.
MYPI87002280A 1984-04-23 1987-09-29 Antibacterial compounds. MY102089A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1984/000212 WO1985004879A1 (en) 1984-04-23 1984-04-23 Cephem compounds
PCT/JP1984/000270 WO1985005620A1 (en) 1984-05-25 1984-05-25 Cephem compounds
PCT/JP1985/000102 WO1986005184A1 (en) 1985-03-01 1985-03-01 Antibacterial compound
EP85104687A EP0160252B1 (en) 1984-04-23 1985-04-18 Antibacterial compounds

Publications (1)

Publication Number Publication Date
MY102089A true MY102089A (en) 1992-03-31

Family

ID=13818317

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002280A MY102089A (en) 1984-04-23 1987-09-29 Antibacterial compounds.

Country Status (6)

Country Link
AT (1) ATE79882T1 (en)
DK (1) DK179985A (en)
HU (1) HU195966B (en)
MY (1) MY102089A (en)
WO (1) WO1985004879A1 (en)
ZA (1) ZA853017B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023798A1 (en) * 1995-01-30 1996-08-08 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use

Also Published As

Publication number Publication date
HU195966B (en) 1988-08-29
ATE79882T1 (en) 1992-09-15
DK179985A (en) 1985-10-24
WO1985004879A1 (en) 1985-11-07
HUT40444A (en) 1986-12-28
ZA853017B (en) 1986-12-30
DK179985D0 (en) 1985-04-22

Similar Documents

Publication Publication Date Title
GR3005315T3 (en)
ES8707223A1 (en) Benzothiazole and benzothiophene derivatives.
GR3036253T3 (en) Cyclopropyl alkanoic acid derivatives
ES8801290A1 (en) Antibacterial compounds, their production and use.
ES8503686A1 (en) Penicillin derivatives and process for preparation of the same.
ES2001341A6 (en) Novel guanidinomethylbenzoic acid derivatives.
ES8800122A1 (en) Indene and naphthalene derivatives.
IE43847L (en) N-substituted phenylpiperidine derivatives.
EP0342665A3 (en) Physiologically active substance tan-931, its derivatives, their production and use
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
NO941084L (en) Neuroleptic 2-substituted perhydro-1-H-pyrido [1,2-alpha-pyrazines
AU6902781A (en) Derivatives of indolobenzoxazine
GB2014141A (en) 8???-ethyl- and 8???-methyl-4,5??? epoxymorphinan-6-one compounds
EP0312040A3 (en) 2,4-disubstituted derivatives of tetrahydrofuran
AU559732B2 (en) Di-and-tetrahydroguinolylacetic acid esters
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
DE2860750D1 (en) Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
ES480765A1 (en) 2-Guanidinomethyl-indolines, method for their preparation and their pharmaceutical use.
AP9400608A0 (en) "New nicotinic acid derivative".
EP0160969A3 (en) Cephem compounds
JPS5412385A (en) Carbostyril derivative
EP0301466A3 (en) Uricosuric composition
ES481416A1 (en) Terephthalic acid monoamide derivatives, process for preparing the same, and an anti-allergic agent prepared from the same
JPS5430161A (en) 2-aminomethylbenzoxazoles and their pharmaceutically acceptable acid salts
JPS53124262A (en) Methylenomycin a derivatives and their preparation